How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CZ52QGK6OVNLFOT6X2BUOAEG5M.jpg "U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld | Reuters")
U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld | Reuters
AstraZeneca wins EU backing for heart drug, but suffers lung cancer setback | Reuters
Understanding hesitancy with revealed preferences across COVID-19 vaccine types | Scientific Reports
Partnering
Annual Reports
U.S. FDA approves AstraZeneca's lung cancer drugs | Reuters
Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca - The New York Times
AstraZeneca - Research-Based BioPharmaceutical Company
Ethics and transparency - Our Company - AstraZeneca
AstraZeneca to pay $425 million to settle lawsuits over heartburn drugs | The Hill
ADR programme
AstraZeneca | Business | The Guardian
AstraZeneca US
Coronavirus (COVID-19) information & research hub | AstraZeneca
EXCLUSIVE AstraZeneca exploring options for COVID-19 vaccine business - executive | Reuters
Annual report 2022
Transforming AstraZeneca's R&D productivity
How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
Annual Reports
Ethics and transparency - Our Company - AstraZeneca
AstraZeneca - Vivli
AstraZeneca, U.S. agree 500,000 more supplies of COVID-19 antibody cocktail | Reuters
AstraZeneca (@AstraZeneca) / X
